Supreme Court rejects generic drug labeling suits
WASHINGTON (Reuters) – The Supreme Court ruled on Thursday that generic drug companies cannot be sued under state law over allegations that they failed to provide adequate label warnings about potential side effects.
The justices handed a victory to Israel’s Teva Pharmaceutical Industries Ltd, Mylan Inc’s UDL Laboratories and Iceland-based Actavis Inc by overturning U.S. appeals court rulings that allowed such lawsuits.
(Reporting by James Vicini, Editing by Gerald E. McCormick)
Brand new on Raw Story
- Man charged for castrating paraplegic at Philadelphia assisted living home
- California man accused of stabbing father and sawing off his own hands
- First Yuri Gagarin film turns Soviet idol into Russian hero
- Indonesia to use rain-making technology to stop fires
- Obama to call for nuclear cuts in historic Berlin speech
- Hospital investors ‘sold’ on Obamacare despite bumps
- Accused Cleveland kidnapper Ariel Castro to appear today at pre-trial hearing
- Small global warming rise would have ‘alarming’ impact: World Bank
- FBI search for Jimmy Hoffa’s body may last two more days
- Japan finds highly toxic strontium-90 in Fukushima groundwater
Commentary
Republicans’ latest abortion ban is staggeringly stupid
By Ana Marie Cox, The Guardian
The Orange Couch does Mad Men: S6E12, “The Quality of Mercy”
By Amanda Marcotte
The Center For Inquiry Likes Atheism’s Cranky White Guy Image, So Screw You Ladies
By Amanda Marcotte
Raw Exclusives
Featured Video
Follow Us!
